Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel Disease

Keyphrases

• Inflammatory Bowel Disease 100%
• Small Molecules 100%
• Drug-induced Liver Injury 100%
• Combined Therapy 66%
• Biological Products 66%
• Adverse Events 33%
• Biological Agents 33%
• Therapeutic Potential 33%
• Methotrexate 33%
• Remission 33%
• New Drugs 33%
• Anti-tumor Necrosis Factor (anti-TNF) 33%
• Multidisciplinary Team 33%
• Anti-tumor Necrosis Factor Agents 33%
• Small Molecule Therapy 33%
• Personalized Management 33%
• Monotherapy 33%
• Thiopurines 33%
• Hepatotoxicity 33%
• New Biologics 33%
• Liver Function Tests 33%
• Traditional Therapy 33%

Medicine and Dentistry

• Biological Product 100%
• Inflammatory Bowel Disease 100%
• Toxic Hepatitis 100%
• Combined Therapy 66%
• Adverse Event 33%
• Tumor Necrosis 33%
• TNF Inhibitor 33%
• Patient with Inflammatory Bowel Disease 33%
• Methotrexate 33%
• Mercaptopurine 33%
• Monotherapy 33%
• Liver Toxicity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Biological Product 100%
• Toxic Hepatitis 100%
• Adverse Event 33%
• Remission 33%
• Tumor Necrosis 33%
• Tumor Necrosis Factor Inhibitor 33%
• Monotherapy 33%
• Hepatotoxicity 33%
• Mercaptopurine 33%
• Methotrexate 33%